Dopamine perturbation of gene co-expression networks reveals differential response in schizophrenia for translational machinery
- PMID: 30546022
- PMCID: PMC6293320
- DOI: 10.1038/s41398-018-0325-1
Dopamine perturbation of gene co-expression networks reveals differential response in schizophrenia for translational machinery
Abstract
The dopaminergic hypothesis of schizophrenia (SZ) postulates that positive symptoms of SZ, in particular psychosis, are due to disturbed neurotransmission via the dopamine (DA) receptor D2 (DRD2). However, DA is a reactive molecule that yields various oxidative species, and thus has important non-receptor-mediated effects, with empirical evidence of cellular toxicity and neurodegeneration. Here we examine non-receptor-mediated effects of DA on gene co-expression networks and its potential role in SZ pathology. Transcriptomic profiles were measured by RNA-seq in B-cell transformed lymphoblastoid cell lines from 514 SZ cases and 690 controls, both before and after exposure to DA ex vivo (100 μM). Gene co-expression modules were identified using Weighted Gene Co-expression Network Analysis for both baseline and DA-stimulated conditions, with each module characterized for biological function and tested for association with SZ status and SNPs from a genome-wide panel. We identified seven co-expression modules under baseline, of which six were preserved in DA-stimulated data. One module shows significantly increased association with SZ after DA perturbation (baseline: P = 0.023; DA-stimulated: P = 7.8 × 10-5; ΔAIC = -10.5) and is highly enriched for genes related to ribosomal proteins and translation (FDR = 4 × 10-141), mitochondrial oxidative phosphorylation, and neurodegeneration. SNP association testing revealed tentative QTLs underlying module co-expression, notably at FASTKD2 (top P = 2.8 × 10-6), a gene involved in mitochondrial translation. These results substantiate the role of translational machinery in SZ pathogenesis, providing insights into a possible dopaminergic mechanism disrupting mitochondrial function, and demonstrates the utility of disease-relevant functional perturbation in the study of complex genetic etiologies.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures


Similar articles
-
Transcriptomic signatures of schizophrenia revealed by dopamine perturbation in an ex vivo model.Transl Psychiatry. 2018 Aug 16;8(1):158. doi: 10.1038/s41398-018-0216-5. Transl Psychiatry. 2018. PMID: 30115913 Free PMC article.
-
Transcriptome study of differential expression in schizophrenia.Hum Mol Genet. 2013 Dec 15;22(24):5001-14. doi: 10.1093/hmg/ddt350. Epub 2013 Jul 30. Hum Mol Genet. 2013. PMID: 23904455 Free PMC article.
-
DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia.Transl Psychiatry. 2017 Jan 17;7(1):e1006. doi: 10.1038/tp.2016.253. Transl Psychiatry. 2017. PMID: 28094815 Free PMC article.
-
An integrative functional genomics approach for discovering biomarkers in schizophrenia.Brief Funct Genomics. 2011 Nov;10(6):387-99. doi: 10.1093/bfgp/elr036. Epub 2011 Dec 8. Brief Funct Genomics. 2011. PMID: 22155586 Free PMC article. Review.
-
Path from schizophrenia genomics to biology: gene regulation and perturbation in neurons derived from induced pluripotent stem cells and genome editing.Neurosci Bull. 2015 Feb;31(1):113-27. doi: 10.1007/s12264-014-1488-2. Epub 2015 Jan 9. Neurosci Bull. 2015. PMID: 25575480 Free PMC article. Review.
Cited by
-
Membrane Nanoscopic Organization of D2L Dopamine Receptor Probed by Quantum Dot Tracking.Membranes (Basel). 2021 Jul 30;11(8):578. doi: 10.3390/membranes11080578. Membranes (Basel). 2021. PMID: 34436341 Free PMC article.
-
Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia.Front Pharmacol. 2020 Jul 14;11:1003. doi: 10.3389/fphar.2020.01003. eCollection 2020. Front Pharmacol. 2020. PMID: 32765257 Free PMC article. Review.
-
Altered estradiol-dependent cellular Ca2+ homeostasis and endoplasmic reticulum stress response in Premenstrual Dysphoric Disorder.Mol Psychiatry. 2021 Nov;26(11):6963-6974. doi: 10.1038/s41380-021-01144-8. Epub 2021 May 25. Mol Psychiatry. 2021. PMID: 34035477 Free PMC article.
-
Modeling common and rare genetic risk factors of neuropsychiatric disorders in human induced pluripotent stem cells.Schizophr Res. 2024 Nov;273:39-61. doi: 10.1016/j.schres.2022.04.003. Epub 2022 Apr 20. Schizophr Res. 2024. PMID: 35459617 Free PMC article. Review.
-
From Schizophrenia Genetics to Disease Biology: Harnessing New Concepts and Technologies.J Psychiatr Brain Sci. 2019;4:e190014. doi: 10.20900/jpbs.20190014. Epub 2019 Sep 19. J Psychiatr Brain Sci. 2019. PMID: 31555746 Free PMC article.
References
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th Edition. Washington, DC: American Psychiatric Publishing; 2013.
Publication types
MeSH terms
Substances
Grants and funding
- R01 MH061675/MH/NIMH NIH HHS/United States
- U01 MH046276/MH/NIMH NIH HHS/United States
- U01 MH079469/MH/NIMH NIH HHS/United States
- R01 MH094116/MH/NIMH NIH HHS/United States
- R01 MH067257/MH/NIMH NIH HHS/United States
- R01 MH060870/MH/NIMH NIH HHS/United States
- R01 MH081800/MH/NIMH NIH HHS/United States
- R01 MH059571/MH/NIMH NIH HHS/United States
- R01 MH106575/MH/NIMH NIH HHS/United States
- R01 MH059565/MH/NIMH NIH HHS/United States
- U01 MH079470/MH/NIMH NIH HHS/United States
- R01 MH059587/MH/NIMH NIH HHS/United States
- R01 MH094091/MH/NIMH NIH HHS/United States
- R01 MH059586/MH/NIMH NIH HHS/United States
- C06 RR020547/RR/NCRR NIH HHS/United States
- R01 MH059566/MH/NIMH NIH HHS/United States
- R01 MH059588/MH/NIMH NIH HHS/United States
- RC2 MH090030/MH/NIMH NIH HHS/United States
- R01 MH060879/MH/NIMH NIH HHS/United States